Plasminogen activation is the central event in fibrinolysis, which is of importance to the strategy of short term treatments of acute thrombolytic disorders. Plasminogen activation also plays critical roles in cell migration related to tumor growth and metastasis, Alzheimer's disease and related cerebral hemorrhage and some pathogenic invasions. Streptokinase, a bacterial protein, is a plasminogen activator widely used in the clinical treatment of myocardial infarction and other clotting disorders. Unlike tissue plasminogen activator and urokinase, streptokinase is not a protease. Streptokinase and plasminogen form a non-covalent complex, which is proteolytically active and converts other plasminogen molecules to plasmin leading to fibrinolysis. Previously, we determined the crystal structures of the catalytic domains of plasminogen and plasmin and the structure of streptokinase. While these structures have provided significant insight into the plasminogen activation and interactions between streptokinase and plasminogen, they also raise new questions about the detailed mechanisms by which the plasminogen:streptokinase complex activates other plasminogen molecules and about the regulation of plasminogen activation by a variety of effectors. The current application proposes to address questions on the mechanism of nonproteolytic activation of plasminogen in the plasminogen:streptokinase complex, the interaction of the substrate plasminogen with the activator complex and interactions between plasminogen activation and some of its physiological/pathological effectors using mutagenesis and x-ray crystallographic approaches.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Hasan, Ahmed AK
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oklahoma Medical Research Foundation
Oklahoma City
United States
Zip Code
Terzyan, Simon; Wakeham, Nancy; Zhai, Peng et al. (2004) Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain. Proteins 56:277-84
Zhu, Guangyu; Zhai, Peng; He, Xiangyuan et al. (2003) Crystal structure of the human GGA1 GAT domain. Biochemistry 42:6392-9
Zhu, Guangyu; He, Xiangyuan; Zhai, Peng et al. (2003) Crystal structure of GGA2 VHS domain and its implication in plasticity in the ligand binding pocket. FEBS Lett 537:171-6
Zhai, Peng; Wakeham, Nancy; Loy, Jeffrey A et al. (2003) Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation. Biochemistry 42:114-20
He, Xiangyuan; Zhu, Guangyu; Koelsch, Gerald et al. (2003) Biochemical and structural characterization of the interaction of memapsin 2 (beta-secretase) cytosolic domain with the VHS domain of GGA proteins. Biochemistry 42:12174-80
Wakeham, N; Terzyan, S; Zhai, P et al. (2002) Effects of deletion of streptokinase residues 48-59 on plasminogen activation. Protein Eng 15:753-61
Loy, J A; Lin, X; Schenone, M et al. (2001) Domain interactions between streptokinase and human plasminogen. Biochemistry 40:14686-95
Wang, X; Terzyan, S; Tang, J et al. (2000) Human plasminogen catalytic domain undergoes an unusual conformational change upon activation. J Mol Biol 295:903-14
Wang, X; Tang, J; Hunter, B et al. (1999) Crystal structure of streptokinase beta-domain. FEBS Lett 459:85-9
Wang, X; Lin, X; Loy, J A et al. (1998) Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 281:1662-5